Hosted on MSN1mon
Vifor Pharma offers £23m to NHS to resolve CMA investigationThe UK’s Competition and Markets Authority (CMA) has received a £23m ($29m) offer from Vifor Pharma for the NHS to address competition concerns that the regulator has been investigating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback